Factors Associated to Medication Consumption Among the Immigrant Population Residing in Spain

  • Díaz-Rodríguez Dania Rocío
  • Hernández-Barrera Valentín
  • Jiménez-Trujillo Isabel
  • Carrasco-Garrido Pilar
Original Paper
  • 61 Downloads

Abstract

We aimed to determine the prevalence of medication use by the immigrant population residing in Spain, and to identify the factors associated with this consumption. Descriptive cross-sectional study was performed using secondary data retrieved from the 2012 Spanish National Health Survey (SNHS). Using logistic multivariate regression analysis, three models were generated: one for immigrants from high income countries (HIC), another for immigrants from low income countries (LIC), and a third one for the native population. The prevalence of total consumption of medicinal products is greater in the native population (61.75%) than in the immigrant population (HIC: 56.22%; LIC: 48.55%). Analgesics are the most consumed drugs in all the groups. Greater medication consumption is associated with being female, being of an advanced age (immigrants from HIC: AOR 9.75, for older than 75 years), the presence of chronic disease, a perception of bad health (HIC: AOR 3.48) and the use of emergency services (LIC immigrants: AOR 1.68). Medicine consumption in the immigrant population living in Spain is lower than in the native population. The factors associated with this consumption are similar; however, LIC immigrants who needed healthcare services and did not receive them presented a greater probability of consuming medicinal products.

Keywords

Immigrants Medications consumption Associated factors Healthcare services 

Notes

Funding

This study was funded by the FIS [Fondo de Investigaciones Sanitarias—Health Research Fund, grant no. PI13/00369, Instituto de Salud Carlos III] co-financed by the European Union through the Fondo Europeo de Desarrollo Regional [FEDER, “Una manera de hacer Europa”]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors. This Project doesn’t need any certificate from the ethics committee, given the nature of such research. All the surveys analyzed were anonymous and dissociated and no personal information is recognized. It’s in accordance with what is stated in the second paragraph, point 5 (Orden SAS/3470/2009, December 16th) and not being within the assumptions established in Article 2.e (Law 14/2007, June 3rd) concerning Biomedical Research.

Informed consent

No informed consent was required.

References

  1. 1.
    Organización Internacional para las Migraciones., Organización Mundial de la Salud., Alto Comisionado de Naciones Unidas para las Migraciones. Migración internacional, salud y derechos humanos. Ginebra 2013;(Monograph):65.Google Scholar
  2. 2.
    Suarez J, Marquez M. Organización Panamericana de la Salud, Organización Mundial de la Salud. Los Proyectos Locales de Promoción de la Salud. Nuevos Escenarios para el Desarrollo de la Salud Pública. Serie Desarrollo de la Representación OPS/OMS en Cuba no 19, 1995. Disponible en: http://www.paho.org/cub/index.php?gid=63&option=com_docman&task=doc_download.
  3. 3.
    Kristiansen M, Mygind A, Krasnik A. Health effects of migration. Dan Med Bull. 2007;54(1):46–7.PubMedGoogle Scholar
  4. 4.
    Rivera B, Casal B, Cantarero D, Pascual M. Adaptación de los servicios de salud a las características específicas y de utilización de los nuevos españoles. Informe SESPAS. 2008. Gac Sanit. 2008;22(Supl 1):86–95.CrossRefGoogle Scholar
  5. 5.
    Malmusi D, Gotsens M (coordinadores). Estado de salud, determinantes y uso de servicios de la población inmigrada en España. Encuestas Nacionales de Salud 2006 y 2012. CIBERESP. 2014;(Monograph):109.Google Scholar
  6. 6.
    Comisión Europea C. Declaración de Amsterdam 2005. «MFH-Hospitales amigos del inmigrante». Disponible en: http://www.mfh-eu.net/public/files/european_recommendations/mfh_amsterdam_declaration_spanish.pdf.
  7. 7.
    Ahonen E, Benavides F, Benach J. Immigrant populations, work and health—a systematic literature review. Scand J Work Environ Health. 2007;33(2):96–104.CrossRefPubMedGoogle Scholar
  8. 8.
    Instituto Nacional de Estadística I. Estadísticas del padrón continuo. Población a 1 de Enero de cada año. Disponible en: http://www.ine.es/prensa/padron_tabla.htm.
  9. 9.
    Oliva J, Pérez G. Inmigración y Salud. Gac Sanit. 2009;23:1–3.CrossRefPubMedGoogle Scholar
  10. 10.
    Comisión Europea C. Eurostat Staticstic explained. Migration and migrant population statistics. Data from May 2014. Most recent data: Further Eurostat information, Main tables and Database. Disponible en: http://ec.europa.eu/eurostat.
  11. 11.
    INE Instituto Nacional de Estadística España en cifras 2014. INE; 2014. Disponible en: http://www.ine.es/prodyser/espa_cifras/2014/files/assets/common/downloads/publication.pdf.
  12. 12.
    Carrasco-Garrido P, De Miguel A, Barrera V, Jiménez-García R. Health profiles, lifestyles and use of health resources by the immigrant population resident in Spain. Eur J Public Health. 2007;17(5):503–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Jiménez D, Hernández C. Diferencias en la automedicación en la población adulta española según el país de origen. Gac Sanit. 2010;24(2):116e1–8.CrossRefGoogle Scholar
  14. 14.
    Carrasco-Garrido P, Jiménez-García R, Hernández Barrera V, López de Andrés A, Gil de Miguel A. Patterns of medication use in the immigrant population resident in Spain: associated factors. Pharmacoepidemiol Drug Saf. 2009;18(8):743–50.CrossRefPubMedGoogle Scholar
  15. 15.
    Jiménez-Rubio D, Hernández-Quevedo C. Explaining the demand for pharmaceuticals in Spain: are there differences in drug consumption between foreigners and the Spanish population? Health Policy. 2010;97(2–3):217–24.CrossRefPubMedGoogle Scholar
  16. 16.
    Carrasco-Garrido P, Hernandez-Barrera V, López de Andrés A, Jiménez-Trujillo I, Jiménez-García R. Sex–differences on self-medication in Spain. Pharmacoepidemiol Drug Saf. 2010;19(12):1293–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Alomar A, Moscoso N, Larrosa J. Determinantes del acceso a los medicamentos: el caso argentino. Anales de la Asociación de Economía Política, 2006. I.S.B.N.: 987-99570-4-0. Disponible en: http://www.aaep.org.ar/anales/works/works2006/Alomar_Moscoso_Larrosa.pdf.
  18. 18.
    Jiménez-Martín S, Jorgensen N. Inmigración y demanda de seguros sanitarios. Gac Sanit. 2009;23(Supl 1):19–24.CrossRefPubMedGoogle Scholar
  19. 19.
    Instituto de Salud Pública Madrid. Inmigración, salud y servicios sanitarios. La perspectiva de la población inmigrante. Documentos Técnicos Salud Pública. 2005;91(Monograph):70.Google Scholar
  20. 20.
    Llop-Gironés A, Vargas Lorenzo I, García-Subirats I, Aller M-B, Navarrete V, Luisa M. Acceso a los servicios de salud de la población inmigrante en España. Rev Esp Salud Pública. 2014;88(6):715–34.CrossRefPubMedGoogle Scholar
  21. 21.
    Acuña C, Marin N, Mendoza A, Martins I, Luiza V, Botello T. Determinantes sociales de la exclusión a los servicios de salud y a medicamentos en tres países de América Central. Rev Panam Salud Publica. 2014;35(2):128–35.PubMedGoogle Scholar
  22. 22.
    Instituto Nacional de Estadística I. Encuesta Nacional de Salud 2011–2012. Disponible en: http://www.ine.es/jaxi/menu.do?type=pcaxis&path=/t15/p419&file=inebase.
  23. 23.
    International Monetary Fund World Economic Outlook. Slowing Growth, Rising Risks. Disponible en: http://www.imf.org/external/pubs/ft/weo/2011/02/pdf/text.pdf.
  24. 24.
    Domingo-Salvany A, Bacigalupe A, Carrasco J, Espelt A, Ferrando J, Borrell C. Propuestas de clase social neoweberiana y neomarxista a partir de la Clasificación Nacional de Ocupaciones 2011. Gac Sanit. 2013;27(3):263–72.CrossRefPubMedGoogle Scholar
  25. 25.
    Bellón Saameño JA, Delgado Sánchez A, Luna del Castillo JD, Lardelli Claret P. Validity and reliability of the Duke-UNC-11 questionnaire of functional social support. Aten Primaria. 1996;18(4):153–6, 158–63.PubMedGoogle Scholar
  26. 26.
    Huang C, Mehta NK, Elo IT, Cunningham SA, Stephenson R, Williamson DF, et al. Region of birth and disability among recent U.S. immigrants: evidence from the 2000 census. Popul Res Policy Rev. 2011;30(3):399–418.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Villarroel N, Artazcoz L. Different patterns in health care use among immigrants in Spain. J Immigr Minor Health. 2016;18(2):318–29.CrossRefPubMedGoogle Scholar
  28. 28.
    Gimeno-Feliu LA, Calderón-Larrañaga A, Prados-Torres A, Revilla-López C, Díaz E. Patterns of pharmaceutical use for immigrants to Spain and Norway: a comparative study of prescription databases in two European countries. Int J Equity Health. 2016;15:32.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    French DP, James DH. Reasons for the use of mild analgesics among English students. Pharm World Sci. 2008;30(1):79–85.CrossRefPubMedGoogle Scholar
  30. 30.
    Kontogiorgis C, Nena E, Berberoglou E, Moschoni K, Polyzois S, Tselemponis A, et al. Estimating consumers’ knowledge and attitudes towards over-the-counter analgesic medication in Greece in the years of financial crisis: the case of paracetamol. Pain Ther. 2016;5(1):19–28.CrossRefPubMedGoogle Scholar
  31. 31.
    Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800.CrossRefGoogle Scholar
  32. 32.
    Dale O, Borchgrevink PC, Fredheim OMS, Mahic M, Romundstad P, Skurtveit S. Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: impact of gender, age, exercise and prescription of opioids. BMC Public Health. 2015;15(1):461.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Carrasco-Garrido P, de Andrés AL, Barrera VH, Jiménez-Trujillo I, Fernández-de-las-Peñas C, Palacios-Ceña D, et al. Predictive factors of self-medicated analgesic use in Spanish adults: a cross-sectional national study. BMC Pharmacol Toxicol. 2014;15:36.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Rue M, Bosh A, Serna M, Soler-González J, Galván L, Cruz I. Estudio observacional del gasto farmacéutico en población inmigrante y autóctona de la región sanitaria de Lleida (Cataluña). Aten Primaria. 2010;42(6):328–37.CrossRefPubMedGoogle Scholar
  35. 35.
    Onrubia J. Vivienda e inmigración en España: Situación y políticas públicas. Presupuesto y Gasto Público. 2010;4(61):273–310.Available in: http://www.ief.es/documentos/recursos/publicaciones/revistas/presu_gasto_publico/61_15.pdf [Acceded 28 March-17].
  36. 36.
    Jansà JM, García de Olalla P. Salud e inmigración: nuevas realidades y nuevos retos. Gac Sanit. 2004;18(4):207–13.CrossRefPubMedGoogle Scholar
  37. 37.
    Achotegui J. Emigrar hoy en situaciones extremas. El síndrome de Ulises. Aloma: Revista de Psicologia, Ciències de l’Educació i de l’Esport. 2012. Disponible en: http://www.revistaaloma.net/index.php/aloma/article/view/171.
  38. 38.
    Taylor SJC, Carnes D, Homer K, Kahan BC, Hounsome N, Eldridge S, et al. Novel three-day, community-based, nonpharmacological group intervention for chronic musculoskeletal pain (COPERS): a randomised clinical trial. PLoS Med. 2016;13(6):e1002040.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Achotegui J. Migración y salud mental. El síndrome del inmigrante con estrés crónico y múltiple (Síndrome de Ulises). Zerbitzuan. 2009;46:163–171. Available https://dialnet.unirioja.es/descarga/articulo/3119470.pdf [Acceded 28 March 2017].
  40. 40.
    Novak SP, Håkansson A, Martínez-Raga J, Reimer J, Krotki K, Varughese S. Nonmedical use of prescription drugs in the European Union. BMC Psychiatry. 2016;16:274.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Sans S, Paluzie G, Puig T, Balañá L, Balaguer-Vintró I. Prevalence of drug utilization in the adult population of Catalonia, Spain. Gac Sanit. 2002;16(2):121–30.CrossRefPubMedGoogle Scholar
  42. 42.
    Carrera-Lasfuentes P, Aguilar-Palacio I, Clemente Roldán E, Malo Fumanal S, Rabanaque Hernández MJ. Consumo de medicamentos en población adulta: influencia del autoconsumo. Aten Primaria. 2013;45(10):528–35.CrossRefPubMedGoogle Scholar
  43. 43.
    Gerritsen AAM, Bramsen I, Devillé W, van Willigen LHM, Hovens JE, van der Ploeg HM. Use of health care services by Afghan, Iranian, and Somali refugees and asylum seekers living in The Netherlands. Eur J Public Health. 2006;16(4):394–9.CrossRefPubMedGoogle Scholar
  44. 44.
    Pokela N, Simon Bell J, Lihavainen K, Sulkava R, Hartikainen S. Analgesic use among community-dwelling people aged 75 years and older: a population-based interview study. Am J Geriatr Pharmacother. 2010;8(3):233–44.CrossRefPubMedGoogle Scholar
  45. 45.
    Borrell C, Muntaner C, Gil-González D, Artazcoz L, Rodríguez-Sanz M, Rohlfs I, et al. Perceived discrimination and health by gender, social class, and country of birth in a Southern European country. Prev Med. 2010;50(1–2):86–92.CrossRefPubMedGoogle Scholar
  46. 46.
    Borrell C, Artazcoz L. Las desigualdades de género en salud: retos para el futuro. Rev Esp Salud Pública. 2008;82(3):241–9.CrossRefGoogle Scholar
  47. 47.
    Zlotnik H. The global dimensions of female migration [Internet]. migrationpolicy.org. 2003. Disponible en: http://www.migrationpolicy.org/article/global-dimensions-female-migration.
  48. 48.
    Ministerio de Sanidad, Servicios Sociales e Igualdad - Instituto de la Mujer - Mujeres migrantes. Disponible en: http://www.inmujer.gob.es/areasTematicas/multiDiscriminacion/mujeresMigrantes/home.htm.
  49. 49.
    Gentil I. Salud y mujeres inmigrantes latinoamericanas: autoestima y resiliencia. Index Enferm. 2009;18(4):229–33.CrossRefGoogle Scholar
  50. 50.
    Formiga F, Ferrer A, Sanz H, Marengoni A, Alburquerque J, Pujol R. Patterns of comorbidity and multimorbidity in the oldest old: the octabaix study. Eur J Intern Med. 2013;24(1):40–4.CrossRefPubMedGoogle Scholar
  51. 51.
    de Letona JML, Patiño FB, Jiménez A, Villares P. El anciano polimedicado: efectos sobre su salud y sobre el sistema sanitario. Información Terapéutica del Sistema Nacional de Salud. 2005;29(6):152–66.Google Scholar
  52. 52.
    Verhagen I, Ros WJ, Steunenberg B, Laan W, de Wit NJ. Differences in health care utilisation between elderly from ethnic minorities and ethnic Dutch elderly. Int J Equity Health. 2014;13:125.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    San-José A, Agustí A, Vidal X, Formiga F, Gómez-Hernández M, García J, et al. Inappropriate prescribing to the oldest old patients admitted to hospital: prevalence, most frequently used medicines, and associated factors. BMC Geriatr. 2015;15:42.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Daniel GW, Malone DC. Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs. J Manag Care Pharm. 2007;13(2):142–54.PubMedGoogle Scholar
  55. 55.
    Tormo M-J, Salmerón D, Colorado-Yohar S, Ballesta M, Dios S, Martínez-Fernández C, et al. Resultados de dos encuestas dirigidas a inmigrantes y nativos del sureste español: salud, uso de servicios y necesidad de asistencia médica. Salud Publica Mex. 2015;57(1):38–49.CrossRefPubMedGoogle Scholar
  56. 56.
    Hernández-Quevedo C, Jiménez-Rubio D. A comparison of the health status and health care utilization patterns between foreigners and the national population in Spain: new evidence from the Spanish National Health Survey. Soc Sci Med. 2009;69(3):370–8.CrossRefPubMedGoogle Scholar
  57. 57.
    Gimeno-Feliu LA, Calderón-Larrañaga A, Díaz E, Poblador-Plou B, Macipe-Costa R, Prados-Torres A. Global healthcare use by immigrants in Spain according to morbidity burden, area of origin, and length of stay. BMC Public Health. 2016;16:450.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Uiters E, Devillé WLJM, Foets M, Groenewegen PP. Use of health care services by ethnic minorities in The Netherlands: do patterns differ? Eur J Public Health. 2006;16(4):388–93.CrossRefPubMedGoogle Scholar
  59. 59.
    Stronks K, Ravelli A, Reijneveld S. Immigrants in the Netherlands: Equal access for equal needs? J Epidemiol Community Health. 2001;55(10):701–7.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Scheppers E, van Dongen E, Dekker J, Geertzen J, Dekker J. Potential barriers to the use of health services among ethnic minorities: a review. Fam Pract. 2006;23(3):325–48.CrossRefPubMedGoogle Scholar
  61. 61.
    Martikainen P, Aromaa A, Heliövaara M, Klaukka T, Knekt P, Maatela J, et al. Reliability of perceived health by sex and age. Soc Sci Med. 1999;48(8):1117–22.CrossRefPubMedGoogle Scholar
  62. 62.
    Moullan Y, Jusot F. Why is the «healthy immigrant effect» different between European countries? Eur J Public Health. 2014;24(Suppl 1):80–6.CrossRefPubMedGoogle Scholar
  63. 63.
    Argeseanu Cunningham S, Ruben JD, Narayan KMV. Health of foreign-born people in the United States: a review. Health Place. 2008;14(4):623–35.CrossRefPubMedGoogle Scholar
  64. 64.
    Rivera B, Casal B, Currais L. Healthy Immigrant Effect: trayectoria de salud de la población inmigrante a partir de la ENSE 2011–2012. Estudios de Economía Aplicada. 2013;31(2):339–5. Available in http://www.redalyc.org/pdf/301/30128236005.pdf. Accessed 28 March 17.
  65. 65.
    Agudelo-Suárez AA, Ronda E, Vázquez-Navarrete ML, García AM, Martínez JM, Benavides FG. Impact of economic crisis on mental health of migrant workers: what happened with migrants who came to Spain to work? Int J Public Health. 2013;58(4):627–31.CrossRefPubMedGoogle Scholar
  66. 66.
    Pérez-Molina J, Pulido Ortega F, Comité de expertos del Grupo para el Estudio del Sida (GESIDA) de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Assessment of the impact of the new health legislation on illegal immigrants in Spain: the case of human immunodeficiency virus infection. Enferm Infecc Microbiol Clin. 2012;30(8):472–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Hospital Universitario del HenaresCosladaSpain
  2. 2.Preventive Medicine and Public Health Teaching and Research Unit, Health Sciences FacultyRey Juan Carlos UniversityAlcorcónSpain

Personalised recommendations